3.8 Article

Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities

Journal

CURRENT GENETIC MEDICINE REPORTS
Volume 7, Issue 2, Pages 63-74

Publisher

SPRINGERNATURE
DOI: 10.1007/s40142-019-00162-x

Keywords

Cancer; Screening; Cancer genomics; Population health; Genetic susceptibility; Public health

Funding

  1. Medical Research Council Clinical Research Training Fellowship [MR/P001106/1]
  2. Ethics Research Fellowship for Health Professionals [200314/Z/15/Z]
  3. Wellcome Trust Society
  4. Wellcome Trust [200314/Z/15/Z] Funding Source: Wellcome Trust
  5. MRC [MR/P001106/1] Funding Source: UKRI

Ask authors/readers for more resources

Purpose of ReviewAs the costs of genomic testing have fallen, and our understanding of genetic susceptibility to cancers has grown, there has been increasing interest in incorporating testing for cancer susceptibility genes, and polygenic risk estimates, into population cancer screening. A growing body of evidence suggests that this would be both clinically and cost-effective. In this article, we aim to explore the frameworks used to evaluate screening programmes, evaluate whether population screening for cancer susceptibility can be assessed using these standards, and consider additional issues and outcomes of importance in this context.Recent FindingsThere are tensions between traditional approaches of genetic testing (utilising tests with high sensitivity and specificity) and the principles of population screening (in which the screening test typically has low specificity), as well as the frameworks used to evaluate the two. Despite the existence of many screening guidelines, including consensus papers, these often do not align fully with broader considerations of genetic test evaluation. Population screening for genetic risk in cancer shifts the focus from diagnostics to prognostication and has wider implications for personal and familial health than existing screening programmes. In addition, understanding of the prevalence and penetrance of cancer susceptibility genes, required by many screening guidelines, may only be obtainable through population-level testing; prospective multi-disciplinary research alongside implementation will be essential.SummaryAppropriate evaluation of genetic screening for cancer risk will require modification of existing screening frameworks to incorporate additional complexity of outcomes and population values. As evidence supporting population screening for cancer susceptibility mounts, development of an appropriate evaluative framework, and expansion of public dialogue will be key to informing policy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available